Antares Pharma Inc. (ATRS) Drops 12.3% on January 11

Equities Staff |

Antares Pharma Inc. (ATRS) was one of the Russell 2000's biggest losers for Monday January 11 as the stock slid 12.3% to $0.92, a loss of $-0.1292 per share. Starting at an opening price of $1.06 a share, the stock traded between $0.91 and $1.09 over the course of the trading day. Volume was 1.78 million shares over 3,853 trades, against an average daily volume of 876,504 shares and a total float of 154.83 million.

The losses send Antares Pharma Inc. down to a market cap of $142.57 million. In the last year, Antares Pharma Inc. has traded between $3.04 and $1.04, and its 50-day SMA is currently $1.31 and 200-day SMA is $1.92.

Antares Pharma Inc is a specialty pharmaceutical company. It is engaged in developing and commercializing self-administered parenteral pharmaceutical products and technologies including novel, pressure-assisted injectors.

Antares Pharma Inc. is based out of Ewing, NJ and has some 93 employees. Its CEO is Eamonn P. Hobbs.

For a complete fundamental analysis analysis of Antares Pharma Inc., check out Equities.com’s Stock Valuation Analysis report for ATRS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Lomiko Metals Inc.

Lomiko Metals Inc is an exploration stage company. It is engaged in the acquisition, exploration and development of resource properties. Its projects include Vines Lake project and Quatre - Milles…

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…

Snapwire

A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.